Senior Director - Neuroscience Communications

Sr. Director, Neuroscience Communications

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work—but it's work worth doing. If you're driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Lilly's Global Corporate Communications function exists to amplify what matters, shape global perception, and protect Lilly's reputation. Every role in our function contributes to four core responsibilities:
Establish Our Story & Thought Leadership, Amplify Business Impact, Brand Protection, and Workforce Engagement.

Neuroscience is one of the most ambitious and fastest-growing businesses in our portfolio, pursuing major therapeutic areas across Alzheimer's disease, psychiatry, sleep-wake medicine, and pain—and building a pipeline that will define the next era of brain health. Our communications needs are evolving alongside the business, requiring modern, innovative, and agile approaches that match the scale and pace of what we are building.

The Sr. Director, Neuroscience Communications is accountable for building and delivering integrated communications strategies across the neuroscience portfolio and pipeline—with the US as the primary market and meaningful global reach. This person works at the intersection of science, business, and storytelling, moving fluidly between setting the long-range narrative architecture and producing polished, deadline-driven work as the business requires. Working closely with the AVP, this role serves as the day-to-day Center of Excellence (COE) partner for the Neuroscience team—briefing, aligning, and holding COE functions accountable to the global strategy.

Key relationships span the broader Global Communications function, Medical, Marketing, Corporate Affairs, and IBU affiliate teams.

Establish Story & Thought Leadership

• Build and maintain the overarching neuroscience communications narrative, connecting Lilly's therapeutic focus areas into a coherent, credible platform story across media, patients, HCPs, and the public
• Ensure brand narrative credibility for Lilly's approved Alzheimer's treatment and future pipeline assets, keeping the story grounded in science and consistent across audiences
• Work alongside the Scientific Communications & Innovation team to shape the scientific narrative architecture underpinning all external neuroscience communications
• Shape the external environment ahead of clinical data releases and regulatory events, building stakeholder understanding before the moment arrives
• Support the visibility and thought leadership of senior Neuroscience leaders, building Lilly's standing as a credible and trusted voice in brain health and neurological disease.

Amplify Business Impact

• Build and deliver integrated global communications strategies for the neuroscience portfolio and pipeline, with the US as the primary market
• Support brand and treatment communications in close coordination with marketing and cross-functional teams, ensuring programs are coherent and well-amplified
• Bring deep expertise in clinical data releases and regulatory communications, working alongside Medical, Scientific Communications, and COE functions to shape rigorous external narratives
• Translate neuroscience communications strategy into clear briefs for COE functions—Earned Media, Content, Digital, and Consumer—ensuring integration and accountability across channels
• Serve as a trusted communications adviser to senior NBU leadership, supporting their visibility, credibility, and effectiveness in high-stakes situations

Brand Protection

• Anticipate and prepare for issues that could affect Lilly's neuroscience portfolio and reputation, spanning competitive dynamics, policy, access, and safety…